Wilson Sonsini Goodrich & Rosati is pleased to sponsor LaunchBio’s Larger Than Life Science: Funding Now, The Current State of Venture Capital Investment in Biopharma.  Expert venture capital panelists answer questions reflecting on the impact on investments during Covid-19 and what the future holds for IPOs and M&A. Walk through top biopharma fund initial assessment, due diligence and investment.  Learn where investors are finding technology, how they are valuing and deciding on opportunities, and how they look at team versus asset/technology.